{"id":987500892,"date":"2024-12-11T17:16:05","date_gmt":"2024-12-11T17:16:05","guid":{"rendered":"https:\/\/boracdmo.com\/bora-wins-at-taiwan-mapect-ceremony\/?lang=en"},"modified":"2025-07-25T13:19:36","modified_gmt":"2025-07-25T13:19:36","slug":"bora-wins-at-taiwan-mapect-ceremony","status":"publish","type":"post","link":"https:\/\/boracdmo.com\/bora-wins-at-taiwan-mapect-ceremony\/","title":{"rendered":"Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A Ceremony: “Deal of the Year” Award and “Best Cross-Border M&A” Award"},"content":{"rendered":"

Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A Ceremony: “Deal of the Year” Award and “Best Cross-Border M&A” Award<\/strong><\/h1>\n

The Taiwan Mergers & Acquisition and Private Equity Council announced its winners today in the MAPECT Award Ceremony. Among 149 M&A cases, Bora Pharmaceuticals distinguished itself by winning both the “Deal of the Year\u201d Award and the “Best Cross-Border M&A\u201d Award, showcasing Bora\u2019s exceptional achievements in M&A strategy and global market expansion.<\/p>\n

The selection panel praised Bora as Taiwan’s first large-scale pharmaceutical company to make significant inroads into the U.S. market, and for the synergies demonstrated through its acquisition efforts. Through the acquisition of Upsher-Smith Laboratories (USL), Bora successfully overcame key barriers to enter the world\u2019s largest pharmaceutical market. This acquisition expanded its pediatric neurology product line with VIGADRONE\u00ae (vigabatrin).<\/p>\n

In addition, Bora achieved significant operational synergies in July when USL and TWi Pharmaceuticals completed its logistics integration, transferring TWi USA\u2019s third-party logistics operations to USL\u2019s in-house warehouse. This move significantly improved the Company\u2019s distribution efficiency, reduced management costs, and accelerated revenue growth.<\/p>\n

Bora Group Chairman Bobby Sheng stated: “The post-merger integration process has demonstrated our ability to swiftly adapt and strengthen our Company operation, with long-term operational benefits gradually becoming evident. Our recently acquired sterile injectable fill\/finish facility in Baltimore has also embarked on a two-month equipment upgrade program in November. Once completed, the facility will comply with the latest EU GMP Annex 1 standards. This will not only solidify Bora\u2019s presence in the U.S. CDMO market but also create new opportunities to be a valued partner for our clients in the European market, significantly enhancing our global competitiveness.”<\/p>\n

Looking ahead, Bora will continue to deepen its global business footprint through its dual engine strategy of CDMO and global commercial sales operations. Driven by innovation and operational efficiency, the Company aims to become a leader in the global pharmaceutical industry.<\/p>\n","protected":false},"excerpt":{"rendered":"

Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A Ceremony: “Deal of the Year” Award and “Best Cross-Border M&A” Award The Taiwan Mergers & Acquisition and Private Equity Council announced its winners today in the MAPECT Award Ceremony. Among 149 M&A cases, Bora Pharmaceuticals distinguished itself by winning both the “Deal of the Year\u201d […]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[],"tags":[],"class_list":["post-987500892","post","type-post","status-publish","format-standard","hentry"],"aioseo_notices":[],"acf":[],"_links":{"self":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987500892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/comments?post=987500892"}],"version-history":[{"count":0,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987500892\/revisions"}],"wp:attachment":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media?parent=987500892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/categories?post=987500892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/tags?post=987500892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}